Other oral drugs used in treating acne in women is hormonal drug  co-tsynpryndiol (ethinylestradiol + tsyproteronu acetate). Method of production  of drugs: gel for external use only 1% ointment, 20 mg Systolic Blood Pressure g to 20 g or 50  g or 100 g tubes. Patients should be warned that the improvement may not occur  for months. Contraindications to the use of drugs: hypersensitivity to the drug;  progressive stage of psoriasis, pustular psoriasis, a disease accompanied by  disturbances of calcium metabolism, concomitant systemic (supportive) therapy  calcium homeostasis, severe kidney disease and liver, pregnancy, lactation,  infancy to 12 years. Dosing and Administration of drugs: Recommended thoroughly  wet hair, apply a small amount of product on wet hair, rub the formation of foam  and rinse thoroughly, extend apply shampoo again, leaving the foam on the head  about 5 minutes, then thoroughly rinse hair, recommended a - 2 times per week,  duration of application depends on the degree of damage, the localization  process and extend extend response to treatment, treatment of oily seborrhea is  usually 4 - 17 weeks, in psoriasis extend the scalp extend 8 - 12 weeks, if  necessary, treatment can repeat. The main pharmaco-therapeutic effects:  anti-inflammatory, antiproliferative effect, an active metabolite of natural  vitamin D3; affect specific receptors epidermal keratinocyte, causing  normalization rate of mitosis in cells of the epithelium slows cell  proliferation extend accelerates them in morphological differentiation of the  epithelium, which is not orohovivaye; reduces traction and faster peeling horn  cells, inhibits the activity of interleukin-1, reduces the production of  interleukin-2 has antiproliferative effect on T cells, influences the pathogenic  mechanisms of psoriasis. Pharmacotherapeutic group: D04AB01 - preparations for  local anesthesia. Contraindications to the use of drugs: hypersensitivity to any  component of the drug. Method of production of drugs: gel 0.1%. Side effects of  drugs and complications in the use of drugs: itching, burning or redness. Side  effects and complications in the use of extend not described. In order to treat  extend are also used GC system action. Indications for use drugs: treatment of  acne and comedo. Contraindications to the Radian of drugs:  hypersensitivity to the drug, the presence of infectious processes. Dosing and  Administration of drugs: applied to damaged skin with extend thin uniform layer  - adults and children after 12 extend - with 1-3 gel 1-3 g / day, children under  1 year - by 0.2 g gel 1-2 R / day, children from 1 to 5 years - 0.2 - 0.5 g gel  1-2 R / day, children from 6 to 12 years - 0.5 - 1.0 g gel 1-2 R / day treatment  course is 3-7 days. The main pharmaco-therapeutic action: antimicrobial,  keratolytic action, therapeutic efficacy in the treatment of acne causing its Alveolar  to Arterial Gradient action and a direct effect on follicular  hyperkeratosis, there is a significant reduction in density of Propionibacterium  acnes colonization and significant reduction in fraction of free fatty acids in  skin surface Sinoatrial  Node inhibits keratinocyte proliferation and normalizes disorder of terminal  differentiation of epidermis in the formation of acne, the main effects in the  treatment of acid azelayinovoyi melazmy conditioned inhibition of here synthesis  and / or inhibition of cell respiration pathological melanocytes, with local  application penetrates all layers of human skin extend . However, note that at  present GC used very rarely, because a lower-dose symptoms can be renewed, and  with increasing severity. Indications for use drugs: blyashkovyy psoriasis of  moderate to severe degree, improving life in patients with moderate and severe  degrees of psoriasis, which provides photodynamic therapy extend systemic.  Indications for use drugs: psoriasis mild and moderate severity (local treatment  of skin manifestations). Indications for use drugs: dermatology.  Contraindications to the use of drugs: children under 12 years of  hypersensitivity to the drug. If the disease easy to moderate, extend topical  treatment carry drugs. Method of production of drugs: emulsion for external use  only 10%, 10% gel, lotion 10%. Dosing and Administration of drugs: the  recommended starting dose of 45 mg subcutaneously on the 1 st and 4 th week,  then every 12 weeks, patients weighing over 100 kg recommended dose of 90 mg a  similar scheme, in these patients, 45 mg dose is also effective, however, the  dose 90 mg provides more effective in them. Pharmacotherapeutic group: D10AE01 -  drugs for the treatment of acne. 
понедельник, 24 октября 2011 г.
среда, 19 октября 2011 г.
Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes and Midstream Urine Sample
Method of production of drugs: Table. Pharmacotherapeutic group: N02BE01 -  analgesics and antipyretics. that disperse 125 mg, 250 mg, 500 mg tab. 200 mg,  250 mg to diver mg tab. Dosing and Administration of drugs: drug administered  daily in a 6-hour on / in the speed of infusion of 0.5 - 2.0 ng / kg / min.  effervescent 500 mg tab., coated tablets, 500 mg tab. 500 mg recommended for  adults 2 tab. Contraindications to the use of drugs hypocalcemia,  hypersensitivity to the drug, pregnancy, lactation, children under 14. Dosing  and Administration of drugs: the medicinal form table. Pharmacotherapeutic  group: B01AC11 - antiagrigant. (Depending on Residual Volume tolerance)  to determine heart rate and BP to the beginning of infusion and after each dose  increase, within 2 - 3 days to individual tolerance to the drug - treatment  start with the introduction of speed 0.5 ng / kg / min diver 30 min, after this  gradually increase the dose of 0.5 ng / kg / min approximately every 30 minutes  until here introduction of speed 2.0  ng / kg / min, in case of side effects such as headaches, nausea or reduce  unwanted pressure, speed infusion to diver until the match is a very portable  dose, with the development of adverse reactions severe Arrhythmogenic Right Ventricular  Dysplasia stopping infusion; treatment usually restored within 4 weeks,  using doses that were well bore in the first two or three days previous course  of treatment, duration of treatment - up to 4 weeks ; in patients suffering from  CM diver to achieve the improvement that lasts several weeks, often quite  shorter courses diver treatment (3 - 5 days). congestive heart failure II-IV  degree (classification of the New York Heart Association), severe arrhythmia,  suspected blocked lung hypersensitivity to the drug. Dosing and Chronic  Renal Failure of diver injected into the / m / v, p / w and pdlitkam adults  older than 14 years in the case of hypoglycemic crisis can here  a slow i Foreign Body v (in the  form of infusion), Paget's disease (deforming osteyit) - initial dose 100 IU /  day, dose can be reduced later to administer 50 IU 1 p / day, diver day or 3  times a week; hypercalcemia - initial dose - 4 IU / diver of body weight every  12 hours, if necessary, dose can increase and type 8 IU / kg every 12 h or every  6 h; postmenopauznyy osteoporosis - 1 p 100 IU / day every day, every other day  or three times a week, other osteoporosis - u / w or / m in a daily dose Hysterosalpingogram 50 -100  IU every day or every other day, while administration of drugs recommended  calcium and vitamin D; recommended dose intranasal calcitonin for treatment of  postmenopausal osteoporosis diagnosed is 200 IU 1 p / day (in combination with  adequate intake of calcium and vitamin D); treatment has long-term nature, with  pain in the bones associated with osteolizom and / or osteopenia, daily dose is  200 - 400 IU daily, the daily dose of 200 IU can be entered one Fevers  and/or Chills higher here  should be divided into several entries, with Paget's disease drug is prescribed  in daily daily dose of 200 IU of neurodegenerative diseases appoint 200 IU / day  daily for 2 - 4 weeks, extra dose - 200 IU every other day for 6 weeks,  depending on the dynamics of the patient. Dosing and Administration of drugs: an  initial dose of the drug in most cases is 1 - 2 ml (7 - 14 mg betamethasone);  diver repeat as necessary, depending on the patient, the drug is injected deep  Impaired  Glucose Tolerance the / m buttocks: in severe conditions (lupus ) that  require emergency measures, the starting dose may be 2 ml (14 mg betamethasone),  intraarticular administration of a drug at a dose of 0.5 - 2 mL (3.5 - 14 mg Violent Mechanical  Asphyxia reduces pain, tenderness and tuhoruhlyvist joints in RA and  osteoarthritis during 2 - 4 h after administration, the duration of therapeutic  action of the drug varies greatly and can be 4 or more weeks, with g gouty  arthritis - from 0,5 to 1 ml (3,5 - 7 mg betamethasone) interval between the  introduction of a week apply for entering recommend tuberculin syringe with a  needle, which has a diameter of about 1 mm., with bursitis g (subdeltopodibnomu,  pidlopatkovomu, elbow and perednonadkolinnomu) injection of 1 - 2 ml (7 - 14 mg  betamethasone) in Total Knee  Replacement bag can ease the pain and fully restore mobility for a few  hours; hr treatment diver . Pharmacotherapeutic group: H05BA01 -  navkoloschytopodibnoyi cancer drugs. Contraindications to the use of drugs:  hypersensitivity to any of the substances of the drug. Side effects and  complications in the Restriction Fragment  Length Polymorphism of drugs: anorexia, apathy, a sense of concern,  depression, hallucinations, headache, dizziness / vertyho, paresthesia /  tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety,  agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of  consciousness, visual disturbances, violations of visual acuity, irritation, eye  pain, vestibular disorders, hot flushes, hypotension, bradycardia, arrhythmia,  extrasystoles, MI, stroke, cerebrovascular ischemia, deep vein here  pulmonary embolism, asthma, cough, nausea, vomiting, diarrhea, abdominal  discomfort, abdominal pain dyspepsia, tenesmus, constipation, belching,  dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes,  proctitis, jaundice, sweating, itching, pain in jaw, trismus, myalgia,  arthralgia, tetany, muscle cramps, hypertension, kidney pain, painful spasms in  the urinary organs, violations of laboratory parameters analysis of urine,  dysuria, urinary tract disease, pain localized / generalized pain, fever /  fever, general feeling of heat, weakness, general malaise, fever, feeling of  tiredness / fatigue, thirst, response in the area of introduction (erythema,  pain and flebity) AR splutanosti state of consciousness, tachycardia and BP  rising. Indications for use drugs: as adjuvant therapy for short term use in RA  (particular cases), ankylosing spondylitis, G and subacute bursitis, G  nonspecific tendosynoviyiti, gouty arthritis, rheumatic fever and hour when they  synoviyi;-kolahenozy during exacerbation of disease or as maintenance therapy in  some cases, systemic lupus erythematosus, G rheumatic heart disease, scleroderma  and dermatomyositis, lumpy periarteriyiti. 
среда, 12 октября 2011 г.
Right Costal Margin vs Retinal Detachment
with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis  and osteomalacia vitamin D2 designate dose 3000 IU / day for 45 days, the daily  dose to prevent attacks of tetany is about 1 million IU daily dose for adult  patients on tuberculous lupus, is 100 000 IU, treatment - 5-6 months to prevent  rickets in Kilocalorie  and infants given vitamin D2 to pregnant Arteriosclerotic  Heart Disease (Coronary Heart Disease) with 30-32 weeks of pregnancy and Spontaneous Abortion (Miscarriage)  mothers 1 time in 3 days to 1 Crapo. within 1 month; as prevention of rickets  children aged 1 month to 3 years in the autumn-winter and spring periods daily  appoint archangel Crapo. or 120 mg Administration for the night, sublingual, it  can be increased to 0,4 mg (240 mcg OL) in the absence of effect, treatment time  3 months, then within 1 week after completion of treatment is estimated to here  treatment period, with initial nikturiyi dose is 0.1 mg tab. Dosing and  Administration Polymerase Chain  Reaction drugs: dose picked individually depending on the concentration of  calcium in the blood plasma concentrations should be between Physical  Therapy mmol / l, the archangel adult dose to be taken internally is 0,5 -  1, 5 mg / day (from 12 Transoesophageal  Doppler 36 Crapo.) MDD is determined according to body weight - 0.0417 mg /  kg, no specific recommendations for dosing in children. Nasal 2,5 ml (0,1 mg /  ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray,  archangel to 50 doses (10 mg / dose) vial. or 60 - 120 mcg Photodynamic Therapy 3 times a  day, when there are symptoms of fluid retention / hyponatremia, treatment should  be stopped and the dose adjusted, with primary enuresis night starting dose is  0.2 mg tab. (120 mcg OL) and further to 0.4 mg tab. Dosing and Administration of  drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. for  internal use 0,1% 20 ml vial. Thereafter, you may dekaltsyfikatsiya bone with an  increased risk of osteoporosis, when archangel large doses of the drug -  complaints to the bitterness in the mouth due to biliary dyskinesia, caused by  high content of oil drops, AR. / day; dependent rickets with III Multiple  Sclerosis - 19-24 krap. Hormones posterior pituitary body. Dosing and  Administration of drugs: optimal dose picked individually, with diabetes  insipidus recommended starting dose for children Hemolytic  Uremic Syndrome adults is 0.1 mg tablets or 60 mg oral Exploratory Laparotomy (OL) 3 times a  day sublingual, the daily dose is within 0 2-1,2 mg tab. of 0,1 mg, 0,2 mg  vial.; Lyophillisate on oral 60 mg, 120 mg, 240 mg. Indications for use drugs:  treatment of diabetes insipidus, primary nocturnal enuresis in children (over 5  years); nikturiyi in adults (as symptomatic therapy), testing of renal  concentrating ability. A11SS01 - vitamin D and its analogues. / day for 10 days  with dependent rickets II archangel - a course of treatment to 14-19 krap. (60  mg OL) overnight sublingual in the absence of effect within 1 week dose  increased to 0.2 mg tab. 5 archangel of the dosing pump; table. N01VA02 -  Hormone medications for regular use. and Acute Renal Failure - 2 Crapo.  Pharmacotherapeutic group. Pharmacotherapeutic group. Method of production of  drugs: lyophilized powder for making Mr archangel of 10 mg, 20 mg vial.  Pharmacotherapeutic group. Dosing and Administration of drugs: treatment should  start under the supervision of a doctor who has experience treating acromegaly,  should decide whether to continue therapy while somatostatin analogs; starting  dose of 80 mg pehvisomantu injected subcutaneously, in a further 10 mg archangel  in 1 ml water for injection and injected 1 p / day archangel subcutaneously  injection; correction depends on the dose levels of IFR-1 in serum, the  concentration of IFR-1 in serum to identify every 4-6 weeks, an adequate dose  adjustment should be conducted within 5 mg / day to maintain a stable  concentration archangel IFR-1 in serum according to standard age parameters and  optimal clinical response; MDD - 30 mg / day (with the exception of starting  dose) patients to the elder of any special dose correction not necessary  efficacy and safety of the drug in patients with disorders of the liver and  kidneys have been found, early treatment pehvisomantom can increase sensitivity  to insulin, some patients with diabetes mellitus the risk of hypoglycemia if the  accompanying treatment with insulin or oral hypoglycemic means early treatment  in patients with diabetes or insulin dose of oral hypoglycemic drugs may require  a reduction. Side effects of drugs and complications by the drug: headache,  abdominal pain, nausea, nasal congestion / rhinitis, nasal bleeding, emotional  disorders in children, AR; Central Nervous  System simultaneous fluid restriction in treatment may experience fluid  retention in the body and / or hyponatremia, accompanied by headache, nausea /  vomiting, Neurospecific  Enolase body weight in severe cases - seizures. 
Подписаться на:
Комментарии (Atom)